O Rutgeerts
Overview
Explore the profile of O Rutgeerts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Betsch A, Rutgeerts O, Fevery S, Sprangers B, Verhoef G, Dierickx D, et al.
Blood Rev
. 2018 Apr;
32(6):490-498.
PMID: 29691090
Lymphomas cause significant morbidity and mortality worldwide. A substantial number of patients ultimately relapse after standard treatment. However, the efficacy of these therapies can be counteracted by the patients' immune...
2.
Luyckx A, Schouppe E, Rutgeerts O, Lenaerts C, Koks C, Fevery S, et al.
Bone Marrow Transplant
. 2011 Nov;
47(7):985-92.
PMID: 22041852
To date, myeloid-derived suppressor cells (MDSC) have been best studied in cancer, where they represent an escape mechanism for immune surveillance. MDSC are now also gaining interest in the context...
3.
Sprangers B, Van Wijmeersch B, Luyckx A, Sagaert X, Verbinnen B, Rutgeerts O, et al.
Bone Marrow Transplant
. 2010 Jul;
46(4):586-96.
PMID: 20603621
GvHD is an important complication of allogeneic hematopoietic SCT. Parent-in-F1 models are frequently used to study GvHD immunobiology; the characteristics of parent-in-F1 GvHD vary between strain combinations and induction protocols....
4.
Sprangers B, Van Wijmeersch B, Luyckx A, Sagaert X, De Somer L, Rutgeerts O, et al.
Leukemia
. 2008 Nov;
23(2):340-9.
PMID: 18987665
The role of graft-versus-malignancy reactivity in the effects of allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusion (DLI) for myelodysplastic syndromes is as yet not well established. Clinical data...
5.
Fevery S, Billiau A, Sprangers B, Rutgeerts O, Lenaerts C, Goebels J, et al.
Leukemia
. 2007 May;
21(7):1451-9.
PMID: 17508005
We studied the effect of CTLA-4 blockade on graft-versus-leukemia and graft-versus-host responses in a mouse model of minor histocompatibility-mismatched bone marrow transplantation. Early CTLA-4 blockade induced acute graft-versus-host disease. Delayed...
6.
Devos T, Yan Y, Segers C, Rutgeerts O, Laureys J, Gysemans C, et al.
Transplant Proc
. 2005 Apr;
37(1):516-7.
PMID: 15808695
Unlabelled: To further study the interactions between innate and adaptive immunity in xenotransplantation, we explored the relative contribution of T-cell subsets in vascularized (heart) and cellular (islets) xenografts in a...
7.
Koshiba T, Van Damme B, Kitade H, Rutgeerts O, Tanaka K, Waer M, et al.
Transplant Proc
. 2002 May;
34(3):1033-9.
PMID: 12034295
No abstract available.
8.
Koshiba T, Van Damme B, Lu Y, Yan Y, Rutgeerts O, Overbergh L, et al.
Transplant Proc
. 2002 May;
34(3):748-9.
PMID: 12034170
No abstract available.
9.
Koshiba T, Van Damme B, Ji P, Lu Y, Yan Y, Sefrioui H, et al.
Transplant Proc
. 2001 Mar;
33(1-2):1550-2.
PMID: 11267416
No abstract available.
10.
Billiau A, Sefrioui H, Overbergh L, Rutgeerts O, Goebels J, Waer M
Transplant Proc
. 2001 Mar;
33(1-2):336-7.
PMID: 11266849
No abstract available.